Physician profile
Robert Bien
NPI 1568493120
$3,214.03
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,208 · 2020: $713 · 2021: $914 · 2022: $296 · 2023: $83.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $813.97 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $400.02 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $258.29 | 2019-2022 | |
| Amgen INC. | $211.41 | 2019-2021 | |
| Daiichi Sankyo INC. | $200.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $199.56 | 2019-2023 | Xarelto |
| Zyla Life Sciences, INC. | $130.59 | 2019 | |
| Abbvie INC. | $130.26 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $127.91 | 2019-2021 | |
| Medtronic, INC. | $120.94 | 2021-2022 | |
| Redhill Biopharma INC. | $103.82 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $79.98 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $47.18 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $44.50 | 2019 | |
| Lundbeck LLC | $42.92 | 2020-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $40.51 | 2019 | |
| Sentynl Therapeutics, INC. | $38.67 | 2019 | |
| Allergan, INC. | $38.50 | 2020 | |
| Arbor Pharmaceuticals, INC. | $36.67 | 2019-2021 | |
| Nevro Corp. | $32.24 | 2019 | |
| Assertio Therapeutics, INC. | $25.06 | 2019 | |
| Grt US Holding, INC. | $19.29 | 2020 | |
| Lilly USA, LLC | $18.16 | 2021 | |
| Scilex Pharmaceuticals INC. | $15.96 | 2021 | |
| Mdd US Operations, LLC | $14.29 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.91 | 2019 | |
| Ibsa Pharma INC. | $11.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.